OmniAb, Inc.
NASDAQ:OABIBiotechnology
Healthcare
$5.03 +7.88%
+$0.16 today
- Market cap
- $733.68M
- Beta
- 1.15
- P/E (TTM)
- -5.2
- EPS (TTM)
- -$0.42
52W Low $1.30High $2.79
Volume 1.75M
Average 0.67M
Income Statement
Follow revenue through to earnings.
Revenue
$18.67M
FY 2025 · Annual
-29.3% YoYOperating Income
-$71.52M
FY 2025 · Annual
Net Income
-$64.78M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.75M | 59.08M | 34.16M | 26.39M | 18.67M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 22.06M |
| Gross Profit | 34.75M | 59.08M | 34.16M | 26.39M | (3.39M) |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | -18.2% |
| Research & Development | 39.23M | 48.36M | 56.53M | 55.11M | 47.75M |
| Selling, General & Admin | 16.95M | 24.9M | 33.31M | 30.74M | 29.22M |
| Operating Expenses | 70.36M | 85.73M | 103.58M | 100.89M | 68.13M |
| Depreciation & Amortization | 16.25M | 18.25M | 19.5M | 23.58M | 21.75M |
| EBITDA | (18.09M) | (7.81M) | (44.87M) | (47.83M) | (44.54M) |
| EBITDA Margin | -52.1% | -13.2% | -131.3% | -181.2% | -238.6% |
| Operating Income | (35.61M) | (26.65M) | (69.42M) | (74.5M) | (71.52M) |
| Operating Margin | -102.5% | -45.1% | -203.2% | -282.3% | -383.1% |
| Interest Income | 0 | 587K | 5.06M | 3.11M | 2.66M |
| Interest Expense | 7K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.26M | 587K | 5.06M | 3.09M | 5.22M |
| Income Before Tax | (34.35M) | (26.06M) | (64.36M) | (71.41M) | (66.29M) |
| Pre-Tax Margin | -98.9% | -44.1% | -188.4% | -270.6% | -355.2% |
| Income Tax Expense | (7.31M) | (3.73M) | (13.74M) | (9.38M) | (1.52M) |
| Net Income | (27.04M) | (22.33M) | (50.62M) | (62.03M) | (64.78M) |
| Net Margin | -77.8% | -37.8% | -148.2% | -235.1% | -347.0% |
| EPS (Basic) | (0.24) | (0.26) | (0.51) | (0.61) | (0.57) |
| EPS (Diluted) | (0.24) | (0.26) | (0.51) | (0.61) | (0.57) |
| 114.82M | 85.32M | 99.68M | 102.37M | 113.64M | |
| 114.82M | 85.32M | 99.68M | 102.37M | 113.64M |
OABI Earnings Waterfall · TTM
NASDAQ:OABI · Revenue to Net Income
Key Ratios
EPS$-0.46
Gross Margin12.6%
Net Margin-342.0%
P/E Ratio-4.1
P/S Ratio42.9
Analysis
$28.9M of revenue converted into -$54.3M of net income for the selected period. Gross margin is 12.6% and net margin is -342.0%, showing how much revenue survives after costs and taxes. EPS is $-0.46, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 2, 2026 | |
| 8-K | Current report | Oct 30, 2026 | |
| 10-Q | Quarterly report | Oct 30, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| 10-Q | Quarterly report | Aug 6, 2026 |
How much revenue does OABI generate?
OmniAb, Inc. (OABI) reported $18.67M of revenue in fiscal 2025.
Is OABI profitable?
OmniAb, Inc. (OABI) reported -$64.78M of net income, with a net margin of -347.0%.
Continue the stock analysis
Jump to another research area for this company.